QVT Financial’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-70,996
| Closed | -$12.2M | – | 67 |
|
|
2021
Q3 | $12.2M | Sell |
70,996
-30,400
| -30% | -$3.98M | 0.91% | 22 |
|
|
2021
Q2 | $12.7M | Hold |
101,396
| – | – | 0.84% | 19 |
|
|
2021
Q1 | $13.8M | Hold |
101,396
| – | – | 0.96% | 16 |
|
|
2020
Q4 | $13M | Hold |
101,396
| – | – | 0.72% | 19 |
|
|
2020
Q3 | $11.4M | Hold |
101,396
| – | – | 1.39% | 20 |
|
|
2020
Q2 | $9.66M | Sell |
101,396
-18,868
| -16% | -$1.82M | 1.64% | 21 |
|
|
2020
Q1 | $10.8M | Sell |
120,264
-70,713
| -37% | -$5.5M | 2.52% | 14 |
|
|
2019
Q4 | $10.1M | Hold |
190,977
| – | – | 1.97% | 21 |
|
|
2019
Q3 | $7.55M | Hold |
190,977
| – | – | 1.55% | 21 |
|
|
2019
Q2 | $7.84M | Hold |
190,977
| – | – | 1.66% | 17 |
|
|
2019
Q1 | $8.89M | Hold |
190,977
| – | – | 2.24% | 14 |
|
|
2018
Q4 | $8.32M | Hold |
190,977
| – | – | 2.71% | 14 |
|
|
2018
Q3 | $10.9M | Hold |
190,977
| – | – | 2.82% | 10 |
|
|
2018
Q2 | $9.27M | Sell |
190,977
-182,504
| -49% | -$6.65M | 2.66% | 12 |
|
|
2018
Q1 | $14.1M | Hold |
373,481
| – | – | 1.48% | 15 |
|
|
2017
Q4 | $15.9M | Hold |
373,481
| – | – | 0.89% | 13 |
|
|
2017
Q3 | $13.9M | Sell |
373,481
-106,956
| -22% | -$3.71M | 0.52% | 25 |
|
|
2017
Q2 | $14.6M | Hold |
480,437
| – | – | 0.39% | 29 |
|
|
2017
Q1 | $12.7M | Sell |
480,437
-19,900
| -4% | -$524K | 0.39% | 34 |
|
|
2016
Q4 | $12.8M | Sell |
500,337
-136,427
| -21% | -$4.32M | 0.39% | 35 |
|
|
2016
Q3 | $23M | Sell |
636,764
-65,646
| -9% | -$2.17M | 0.87% | 20 |
|
|
2016
Q2 | $23.9M | Hold |
702,410
| – | – | 1.64% | 18 |
|
|
2016
Q1 | $18.5M | Buy |
702,410
+62,110
| +10% | +$1.81M | 1.14% | 26 |
|
|
2015
Q4 | $31.2M | Sell |
640,300
-221,513
| -26% | -$7.97M | 1.75% | 10 |
|
|
2015
Q3 | $21.5M | Buy |
861,813
+86,564
| +11% | +$2.6M | 0.74% | 22 |
|
|
2015
Q2 | $24.5M | Buy |
775,249
+13,588
| +2% | +$439K | 0.37% | 25 |
|
|
2015
Q1 | $29M | Sell |
761,661
-200,556
| -21% | -$7.98M | 1.61% | 13 |
|
|
2014
Q4 | $37.5M | Sell |
962,217
-231,041
| -19% | -$8.05M | 1.87% | 14 |
|
|
2014
Q3 | $36.1M | Buy |
1,193,258
+39,200
| +3% | +$1.1M | 1.86% | 18 |
|
|
2014
Q2 | $39.2M | Buy |
1,154,058
+597,484
| +107% | +$20M | 2.12% | 14 |
|
|
2014
Q1 | $18.8M | Hold |
556,574
| – | – | 1.08% | 34 |
|
|
2013
Q4 | $21.6M | Buy |
+556,574
| New | +$13.4M | 1.27% | 30 |
|
QVT Financial's XLRN Position: Q4 2021 in Review
QVT Financial sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 70,996 shares — an estimated $12.2M sold.
QVT Financial first reported a position in XLRN in Q4 2013 and held it in 32 quarters. The position peaked at $39.2M in Q2 2014. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- QVT Financial reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- QVT Financial sold 70,996 Acceleron Pharma shares in Q4 2021, an estimated $12.2M.
- QVT Financial first reported a position in Acceleron Pharma in Q4 2013 and held it in 32 quarters.
- QVT Financial's Acceleron Pharma position peaked at $39.2M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on QVT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.